Motor neuronal protection by L-arginine prolongs survival of mutant SOD1 (G93A) ALS mice

J Lee, H Ryu, NW Kowall - Biochemical and biophysical research …, 2009 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by
progressive paralysis due to motor neuron degeneration. Despite the fact that many different …

Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice

J Lee, H Ryu, NW Kowall - Biochemical and biophysical research …, 2009 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder characterized by
degeneration of motor neurons throughout the central nervous system. Mutations of the free …

d‐Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis

J Sasabe, T Chiba, M Yamada, K Okamoto… - The EMBO …, 2007 - embopress.org
Excitotoxicity has been implicated in the pathogenesis of amyotrophic lateral sclerosis
(ALS). More recently, glial involvement has been shown to be essential for ALS‐related …

Intrathecal Delivery of ssAAV9-DAO Extends Survival in SOD1G93A ALS Mice

W Wang, W Duan, Y Wang, D Wen, Y Liu, Z Li… - Neurochemical …, 2017 - Springer
Amyotrophic lateral sclerosis (ALS) is an adult-onset, irreversible neurodegenerative
disease that leads to progressive paralysis and inevitable death 3–5 years after diagnosis …

N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model

W Li, A Fotinos, Q Wu, Y Chen, Y Zhu, S Baranov… - Neurobiology of …, 2015 - Elsevier
Background Whether l-NAT, a cytochrome c release inhibitor and an antagonist of NK-1R,
provides protection in ALS is not known. Results l-NAT delays disease onset and mortality in …

Differences of transport activity of arginine and regulation on neuronal nitric oxide synthase and oxidative stress in amyotrophic lateral sclerosis model cell lines

S Latif, YS Kang - Cells, 2021 - mdpi.com
L-Arginine, a semi-essential amino acid, was shown to delay dysfunction of motor neurons
and to prolong the lifespan, upon analysis of transgenic mouse models of amyotrophic …

d-Amino acid oxidase controls motoneuron degeneration through d-serine

J Sasabe, Y Miyoshi, M Suzuki, M Mita… - Proceedings of the …, 2012 - National Acad Sciences
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder involving an
extensive loss of motoneurons. Aberrant excitability of motoneurons has been implicated in …

Focus on the role of d-serine and d-amino acid oxidase in amyotrophic lateral sclerosis/motor neuron disease (ALS)

NR Kondori, P Paul, JP Robbins, K Liu… - Frontiers in molecular …, 2018 - frontiersin.org
We have investigated a pathogenic mutation in D-amino acid oxidase (DAO), DAOR199W,
associated with familial Amyotrophic Lateral Sclerosis (ALS) that impairs D-serine …

[HTML][HTML] Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral …

M Milanese, F Giribaldi, M Melone, T Bonifacino… - Neurobiology of …, 2014 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a late-onset fatal neurodegenerative disease
reflecting degeneration of upper and lower motoneurons (MNs). The cause of ALS and the …

ROCK inhibition improves axonal regeneration in a preclinical model of amyotrophic lateral sclerosis

AR Joshi, I Muke, I Bobylev… - Journal of Comparative …, 2019 - Wiley Online Library
Alteration of the RhoA/ROCK (Rho kinase) pathway has been shown to be neuroprotective
in SOD1G93A mice, the most commonly used animal model of ALS. Since previous studies …